Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.5298
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.50
Today|||52-Week Range
6.96
-89.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues405.0K1.3M8.3M9.2M
 
 
 
 
 
Cost of Goods Sold411.0K1.0M5.5M6.5M
 
 
 
 
 
Depreciation And Amortization298.0K299.0K748.0K904.0K
 
 
 
 
 
 
Operating ExpensesGross Income-304.0K17.0K2.0M1.8M
 
 
 
 
 
General Expenses13.0M14.6M17.9M17.5M
 
 
 
 
 
Research And Development1.7M2.2M3.0M3.2M
 
 
 
 
 
Total Operating Expenses13.8M15.9M24.1M24.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.3M-14.5M-15.9M-15.7M
 
 
 
 
 
Extraordinary Credit55.0K79.0K--14.0K
 
 
 
 
Extraordinary Charge0.000.00-1.1M--
 
 
Interest Expense On Debt0.00--48.0K43.0K
 
 
 
Other Expenses-24.0K-157.0K-397.0K-584.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-14.5M-17.3M-16.3M
 
 
 
 
 
Income Taxes0.00-15.0K-19.0K-34.0K
 
 
 
 
Discontinued Operations273.0K0.000.000.00
 
 
Net Income-12.9M-14.5M-17.3M-16.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS799.5K936.7K1.3M1.7M
 
 
 
 
 
Shares To Calculate EPS Diluted799.5K936.7K1.3M1.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$16.08-$15.48-$13.80-$111.72
 
 
 
 
 
EPS Diluted-$16.08-$15.48-$13.80-$9.36